PeptAim is our new project based on a combination of artificial intelligence and machine learning for accurate predictions of protein-protein interaction. This platform gives a possibility to design short peptides that have the highest affinity to targeted protein to be further used in diagnostics, therapy and basic science.
Hybridowax is based on our company’s know-how and patents. We are working on developing a new protein-based anti-SARS-CoV2 vaccine.
HPVaid is Advanced Innovative Diagnostics for all human papilloma virus strains. The aim of this project is to develop rapid point of care antigenic test that will allow for sexually active people to detect the papillomavirus infection. We strongly believe that our innovative solution will lead to minimize the spread of the HPV in human population.
Additionally we are starting a cooperation with aqua culture sector in order to develop vaccines and diagnostic tools for most important pathogens of fish and seafood.